Literature DB >> 31853591

Infiltration Depth is the Most Relevant Risk Factor for Overall Metastases in Early Esophageal Adenocarcinoma.

Christina Oetzmann von Sochaczewski1, Thomas Haist2, Michael Pauthner2, Markus Mann2, Susanne Braun3, Christian Ell4, Dietmar Lorenz5.   

Abstract

BACKGROUND: Research in early esophageal adenocarcinoma focused on prediction of lymph node metastases in order to stratify patients for endoscopic treatment instead of esophagectomy. Although distant metastases were described in rates of up to 13% of patients within a follow-up of 3 years, their prediction has been neglected so far.
METHODS: In a secondary analysis, a cohort of 217 patients (53 T1a and 164 T1b) treated by esophagectomy was analyzed for histopathological risk factors. Their ability to predict the combination of lymph node metastases at surgery as well as metachronous locoregional and distant metastases (overall metastatic rate) was assessed by uni- and multivariate logistic regression analysis.
RESULTS: Tumor invasion depth was correlated with both lymph node metastases at surgery (τ = 0.141; P = .012), tumor recurrences (τ = 0.152; P = .014), and distant metastases (τ = 0.122; P = 0.04). Multivariate analysis showed an odds ratio of 1.31 (95% CI 1.02-1.67; P = .033) per increasing tumor invasion depth and of 3.5 (95% CI 1.70-6.56; P < .001) for lymphovascular invasion. The pre-planned subgroup analysis in T1b tumors demonstrated an even lower predictive ability of lymphovascular invasion with an odds ratio of 2.5 (95% CI 1.11-5.65; P = 0.028), whereas the predictive effect of sm2 (odds ratio 3.44; 95% CI 1.00-11.9; P = 0.049) and sm3 (odds ratio 3.44; 95% CI 1.00-11.9; P = 0.049) tumor invasion depth was similar.
CONCLUSIONS: The present report demonstrates the insufficient risk prediction of histopathologic risk factors for the overall metastatic rate.

Entities:  

Year:  2020        PMID: 31853591     DOI: 10.1007/s00268-019-05291-6

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  40 in total

1.  Management of patients with T1b esophageal adenocarcinoma: a retrospective cohort study on patient management and risk of metastatic disease.

Authors:  Dirk Schölvinck; Hannah Künzli; Sybren Meijer; Kees Seldenrijk; Mark van Berge Henegouwen; Jacques Bergman; Bas Weusten
Journal:  Surg Endosc       Date:  2016-06-29       Impact factor: 4.584

2.  The overall prevalence of metastasis in T1 esophageal squamous cell carcinoma: a retrospective analysis of 295 patients.

Authors:  Yasunori Akutsu; Masaya Uesato; Kiyohiko Shuto; Tsuguaki Kono; Isamu Hoshino; Daisuke Horibe; Testutaro Sazuka; Nobuyoshi Takeshita; Tetsuro Maruyama; Yuka Isozaki; Naoki Akanuma; Hisahiro Matsubara
Journal:  Ann Surg       Date:  2013-06       Impact factor: 12.969

3.  Outcome of surgical treatment for early adenocarcinoma of the esophagus or gastro-esophageal junction.

Authors:  Marinke Westerterp; Linetta B Koppert; Christianne J Buskens; Hugo W Tilanus; Fiebo J W ten Kate; Jacques J H G M Bergman; Peter D Siersema; Herman van Dekken; Jan J B van Lanschot
Journal:  Virchows Arch       Date:  2005-04-19       Impact factor: 4.064

Review 4.  The epidemic of oesophageal carcinoma: Where are we now?

Authors:  Aaron P Thrift
Journal:  Cancer Epidemiol       Date:  2016-02-03       Impact factor: 2.984

Review 5.  The risk of lymph-node metastases in patients with high-grade dysplasia or intramucosal carcinoma in Barrett's esophagus: a systematic review.

Authors:  Kerry B Dunbar; Stuart Jon Spechler
Journal:  Am J Gastroenterol       Date:  2012-06       Impact factor: 10.864

6.  Treatment allocation in patients with early-stage esophageal adenocarcinoma: Prevalence and predictors of lymph node involvement.

Authors:  Anthony M Gamboa; Sungjin Kim; Seth D Force; Charles A Staley; Kevin E Woods; David A Kooby; Shishir K Maithel; Jennifer A Luke; Katherine M Shaffer; Sunil Dacha; Nabil F Saba; Steven A Keilin; Qiang Cai; Bassel F El-Rayes; Zhengjia Chen; Field F Willingham
Journal:  Cancer       Date:  2016-05-03       Impact factor: 6.860

7.  Long-term efficacy and safety of endoscopic resection for patients with mucosal adenocarcinoma of the esophagus.

Authors:  Oliver Pech; Andrea May; Hendrik Manner; Angelika Behrens; Jürgen Pohl; Maren Weferling; Urs Hartmann; Nicola Manner; Josephus Huijsmans; Liebwin Gossner; Thomas Rabenstein; Michael Vieth; Manfred Stolte; Christian Ell
Journal:  Gastroenterology       Date:  2013-11-20       Impact factor: 22.682

8.  The overall metastatic rate in early esophageal adenocarcinoma: long-time follow-up of surgically treated patients.

Authors:  C Oetzmann von Sochaczewski; T Haist; M Pauthner; M Mann; A Fisseler-Eckhoff; S Braun; C Ell; D Lorenz
Journal:  Dis Esophagus       Date:  2019-11-13       Impact factor: 3.429

9.  Submucosal Invasive Depth Predicts Lymph Node Metastasis and Poor Prognosis in Submucosal Invasive Esophageal Squamous Cell Carcinoma.

Authors:  Tomohiro Kadota; Tomonori Yano; Takeo Fujita; Hiroyuki Daiko; Satoshi Fujii
Journal:  Am J Clin Pathol       Date:  2017-11-02       Impact factor: 2.493

10.  Serum miR-331-3p predicts tumor recurrence in esophageal adenocarcinoma.

Authors:  Jianchun Gu; Jinhua Zhang; Leizhen Zheng; Jaffer A Ajani; Xifeng Wu; Yuanqing Ye
Journal:  Sci Rep       Date:  2018-09-18       Impact factor: 4.379

View more
  1 in total

Review 1.  Artificial intelligence-assisted endoscopic detection of esophageal neoplasia in early stage: The next step?

Authors:  Yong Liu
Journal:  World J Gastroenterol       Date:  2021-04-14       Impact factor: 5.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.